MyFinsight
Home
Blog
About
Contact
Download
Download image
Advance from/
(repayments to) directors
$80,717
Net cash generated
from/(used in) financing...
$59,709
Foreign currency
translation adjustment
$13,544
Canceled cashflow
$21,008
Net change in cash
and cash...
-$88,406
Canceled cashflow
$73,253
Trade and other
receivables
-$243,016
Trade and other
payables
$187,891
Inventories
-$9,549
Advance payment from
customer
$31
Deposit payment of
finance lease...
$21,008
Net cash used in
operating activities
-$147,671
Canceled cashflow
$440,487
Net cash used in
investing activities
-$13,988
Allowances for expected
credit losses
$202,497
Depreciation of property,
plant and equipment
$28,293
Amortization of operating
lease rou assets
$15,589
Operating loss before
working capital changes
$323,939
Canceled cashflow
$246,379
Other assets
-$249,999
Operating lease
liabilities
-$13,993
Tax liabilities
$227
Change in fixed
deposits placed with...
$13,663
Purchase of plant and
equipment
$325
Net loss
$543,575
Recoveries for expected
credit losses
$26,743
Back
Back
Cash Flow
source: myfinsight.com
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)